Researchers at the University of Missouri have invented a novel method to prevent immunorejection during organ transplantation, graft transplantation, and similar other procedures.
The immune system acts as the body’s first line of defense against foreign antigens such as invading bacteria, virus, and other “non-self” materials. While this defense mechanism is essential to protect us from harmful pathogens, the immune system also mounts a defensive attack against non-pathogenic foreign material such as transplanted organs and tissues intended to replace their failing counterparts. Current methods to counter this immunorejection focus on suppressing the immune system, a high-risk strategy that exposes the patient to a high risk of infection and death.
MU researchers have invented a novel method to prevent immunorejection during organ transplantation, graft transplantation, and similar other procedures.
- Organ and graft transplantation
- Can be used in cases of immune
- Cost effective
- Circumvents the need for immunosuppression
State Of Development: Preclinical; This research is at an early stage. The University of Missouri is seeking interested licensees and/or collaboration partners.
Owner: University of Missouri-Columbia
IP Protection Status: Pending Patent